Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan R Stretch

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
Annals of Surgical Oncology|July 19, 2012
Surgeons' opinions on lymphadenectomy in melanoma patients with positive sentinel nodes: a worldwide web-based surveySandro Pasquali, Andrew J Spillane, Johannes H W de Wilt, et al.
Annals of Surgical Oncology|May 31, 2012
Evaluation of incomplete sentinel node biopsy procedures and sentinel node positivity rates as surgical quality-assurance parameters in melanoma patientsAndrew J Spillane, Lauren E Haydu, Nicholas C Lee, et al.
Annals of Surgical Oncology|May 10, 2015
Minimum Safe Pathologic Excision Margins for Primary Cutaneous Melanomas (1-2 mm in Thickness): Analysis of 2131 Patients Treated at a Single CenterLauren E Haydu, Joram T Stollman, Richard A Scolyer, et al.
Annals of Surgical Oncology|May 8, 2014
Melanoma patients with an unknown primary tumor site have a better outcome than those with a known primary following therapeutic lymph node dissection for macroscopic (clinically palpable) nodal diseaseAugustinus P T van der Ploeg, Lauren E Haydu, Andrew J Spillane, et al.
American Journal of Clinical Pathology|February 6, 2007
Diagnosis of metastatic melanoma by fine-needle biopsy: analysis of 2,204 casesRajmohan Murali, Anna Doubrovsky, Geoffrey F Watson, et al.
Annals of Surgery|July 30, 2014
The optimum excision margin and regional node management for primary cutaneous T3 melanomas (2-4 mm in Thickness): a retrospective study of 1587 patients treated at a single centerLieke G E Lamboo, Lauren E Haydu, Richard A Scolyer, et al.
Annals of Surgical Oncology|June 30, 2022
Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-Transit Melanoma MetastasesAnna K Lawless, David J Coker, Serigne N Lo, et al.
Annals of Surgical Oncology|February 22, 2012
Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanomaRajmohan Murali, Lauren E Haydu, Georgina V Long, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|May 22, 2013
Margins of excision and prognostic factors for cutaneous eyelid melanomasVarun Harish, Jeremy S Bond, Richard A Scolyer, et al.
Annals of Surgery|March 18, 2014
Outcome following sentinel node biopsy plus wide local excision versus wide local excision only for primary cutaneous melanoma: analysis of 5840 patients treated at a single institutionAugustinus P T van der Ploeg, Lauren E Haydu, Andrew J Spillane, et al.
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Annals of Surgical Oncology|July 19, 2012
Surgeons' opinions on lymphadenectomy in melanoma patients with positive sentinel nodes: a worldwide web-based surveySandro Pasquali, Andrew J Spillane, Johannes H W de Wilt, et al.
Annals of Surgical Oncology|May 31, 2012
Evaluation of incomplete sentinel node biopsy procedures and sentinel node positivity rates as surgical quality-assurance parameters in melanoma patientsAndrew J Spillane, Lauren E Haydu, Nicholas C Lee, et al.
Annals of Surgical Oncology|May 10, 2015
Minimum Safe Pathologic Excision Margins for Primary Cutaneous Melanomas (1-2 mm in Thickness): Analysis of 2131 Patients Treated at a Single CenterLauren E Haydu, Joram T Stollman, Richard A Scolyer, et al.
Annals of Surgical Oncology|May 8, 2014
Melanoma patients with an unknown primary tumor site have a better outcome than those with a known primary following therapeutic lymph node dissection for macroscopic (clinically palpable) nodal diseaseAugustinus P T van der Ploeg, Lauren E Haydu, Andrew J Spillane, et al.
American Journal of Clinical Pathology|February 6, 2007
Diagnosis of metastatic melanoma by fine-needle biopsy: analysis of 2,204 casesRajmohan Murali, Anna Doubrovsky, Geoffrey F Watson, et al.
Annals of Surgery|July 30, 2014
The optimum excision margin and regional node management for primary cutaneous T3 melanomas (2-4 mm in Thickness): a retrospective study of 1587 patients treated at a single centerLieke G E Lamboo, Lauren E Haydu, Richard A Scolyer, et al.
Annals of Surgical Oncology|June 30, 2022
Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-Transit Melanoma MetastasesAnna K Lawless, David J Coker, Serigne N Lo, et al.
Annals of Surgical Oncology|February 22, 2012
Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanomaRajmohan Murali, Lauren E Haydu, Georgina V Long, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|May 22, 2013
Margins of excision and prognostic factors for cutaneous eyelid melanomasVarun Harish, Jeremy S Bond, Richard A Scolyer, et al.
Annals of Surgery|March 18, 2014
Outcome following sentinel node biopsy plus wide local excision versus wide local excision only for primary cutaneous melanoma: analysis of 5840 patients treated at a single institutionAugustinus P T van der Ploeg, Lauren E Haydu, Andrew J Spillane, et al.
Pageof 10